Kilitch Drugs (India) Limited has informed the Exchange that the Board of Directors at its meeting held on February 11, 2026, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held.
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has announced a bonus issue of equity shares in the ratio of 1:1, meaning shareholders will receive 1 bonus share for every 1 share they hold. The decision was approved by the Board of Directors at a meeting held on February 11, 2026. This effectively doubles the number of outstanding shares held by existing investors. The record date and other key timelines for the bonus issue are not mentioned in this announcement and are expected to be communicated separately.
This is a highly generous bonus issue at the maximum standard ratio, rewarding existing shareholders by doubling their share count. While the stock price typically adjusts downward proportionally on the ex-date, long-term shareholders benefit from increased liquidity and a larger holdings base, with no cash outflow required.